Vertiv Q3 Beats; Raises FY2025 Guidance

Vertiv reported strong Q3 2025, posting non‑GAAP EPS of $1.24 (about 24% above consensus) and revenue of $2.68 billion, up 29% year‑over‑year with organic sales up 28.4% and product revenues rising 33.9%. Organic orders jumped roughly 60% YoY, the book‑to‑bill was about 1.4x and backlog stood at $9.5 billion (up ~30% vs. 2024 year‑end). Management raised full‑year 2025 revenue and EPS guidance—targeting just over $10 billion in revenue and FY EPS of roughly $4.07–$4.43—while Q4 revenue guidance was slightly above Street estimates but Q4 EBIT and margin guidance was modestly below consensus amid tariff pressures and EMEA headwinds; the company said it is accelerating an EMEA restructuring. The results lifted the stock in pre‑market trading and prompted brokerages including Citigroup, UBS, TD Cowen, RBC, Oppenheimer and Morgan Stanley to reiterate buy/outperform calls and raise price targets; CNBC contributor Stephanie Link disclosed buying more Vertiv shares. Separately, VeriSign also reported Q3 beats with revenue up 7.3% to $419.1 million and GAAP EPS of $2.27, though its longer‑term growth remains modest (five‑year CAGR ~5.3%) and near‑term upside appears limited.